Sam Osman

Advisory Board Member

Over the last two decades, Osman has led or invested in a number of businesses within life sciences. Most recently he served as CEO of Cenduit, an eClinical technology firm from 2016 to 2020 with a successful sale to IQVIA in December 2019. Previously with Quintiles, the world’s largest Contract Research Organization, he oversaw a number of businesses focused on patient centricity, data collection, and safety monitoring including building from scratch the industry’s first and largest connected devices, sensors, and wearables hub. He also held business and corporate development roles successfully closing in excess of $1bn in deals with pharma and biotech customers as well as several M&A and licensing transactions.

Osman holds a BSc in Economics and Biochemistry from the University of Tampa, an MSc in Economics from the London School of Economics, and an MBA with distinction from Carnegie Mellon University. He was named to the PharmaVoice Top 100 Leaders in Healthcare and the Triangle Business Journal 40 under 40 in 2019, and the Top 25 Entrepreneurs in the State of Pennsylvania. Osman currently serves as an advisory board member for three life sciences companies and is a venture partner with a private equity investor.

Areas of Focus